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Zika virus (ZIKV) can cause birth defects in humans and is a serious global 
public health concern. This arbovirus is primarily transmitted to humans by Aedes 
aegypti and Ae. albopictus mosquitoes; however, it can also be transmitted sexually and 
congenitally (from human to human). Vector-virus interactions influencing vector 
competence (the ability for a mosquito to become infected with and transmit a 
pathogen) vary and depend on biological (e.g., mosquito age) and environmental 
factors (e.g., temperature). A mosquito’s chronological age at time of infection may 
impact its immune response against virus infection. There are no effective vaccines for 
most arboviruses, including ZIKV, hence insecticides are the best defense against 
mosquito transmitted ZIKV. Aedes albopictus is difficult to control due to its day-active 
nature and propensity to oviposit in containers throughout landscapes. However, 
residual barrier treatments can control Ae. albopictus and may use pyrethroid 
insecticides, such as bifenthrin. Since the efficacy of barrier spray treatments decreases 
over time due to environmental degradation, we characterized the extent to which 
sublethal bifenthrin exposure impacted vector competence for ZIKV. We exposed young 
(6-7 d post-emergence) and old (11-12 d post-emergence) Ae. albopictus to bifenthrin 
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prior to oral exposure to blood meals containing ZIKV (7-day extrinsic incubation 
period). For this mosquito population, old mosquitoes experienced a significantly 
(P=0.0017) higher rate of mortality than young mosquitoes. Significantly (P=0.003) 
higher body titers were shown in old control group compared to young control group. 
Significantly (P=0.013, P=0.001) higher ZIKV dissemination rates and leg titers were 
observed in old bifenthrin-exposed mosquitoes compared to old control mosquitoes or 
young bifenthrin-exposed or control mosquitoes. This indicates that bifenthrin exposure 
may increase the potential for virus transmission (measured by proxy dissemination rate 
here); however, the degree of these impacts varies with mosquito age. Impacts of 
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CHAPTER I - INTRODUCTION AND PURPOSE OF THE STUDY 
 In the United States, there has been widespread concern about a potential 
epidemic caused by Zika virus (ZIKV; family Flaviviridae, genus Flavivirus). This 
arbovirus is primarily transmitted to humans by Aedes aegypti L. and Ae. albopictus 
Skuse mosquitoes; however, it can also be sexually transmitted between humans. 
Aedes aegypti and Ae. albopictus inhabit regions with tropical, subtropical, and 
temperate climates; however, Ae. albopictus has a broader range in temperate climates, 
compared to Ae. aegypti (Centers for Disease Control and Prevention [CDC] 2016). 
Aedes aegypti is considered the primary vector of ZIKV, dengue virus, and chikungunya 
virus due to its blood feeding preference for humans, whereas Ae. albopictus is an 
opportunistic blood feeder and will feed on any available host, including humans (CDC 
2016).  
 Zika virus is a positive-sense, single-stranded RNA virus of 10,794-nucleotides 
and has three major lineages: East African, West African, and Asian (Chouin-Carneiro 
et al. 2016). Zika virus was first discovered in 1947 in a monkey living in the Zika Forest 
of Uganda (Weaver et al. 2016). The first documented case of a human being infected 
with ZIKV was in Nigeria in 1953 (Petersen et al. 2016). Before the 1980’s, ZIKV’s 
geographic range was restricted to Africa and Asia and the first major human outbreak 
of ZIKV was on Yap Island, Micronesia (2007) (Chouin-Carneiro et al. 2016, Guerbois 
et. al 2016). In subsequent years, ZIKV outbreaks were detected in French Polynesia 
(2013), New Caledonia (2014), Easter Island (2014), the Cook Islands (2014), 
northeastern Brazil (May 2015), and the first documented case of local transmission of 
ZIKV in the United States occurred in July 2016 in Florida (Kindhauser et al. 2016, 
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Chouin-Carneiro et al. 2016). The lineage responsible for the American outbreak of 
ZIKV is the Asian genotype (Chouin-Carneiro et al. 2016). The mild symptoms of ZIKV 
infection include fever, rash, arthritis, and conjunctivitis, while the more severe 
outcomes of ZIKV consists of neurological or auto-immune complications, i.e., Guillain-
Barre syndrome and microcephaly in developing fetuses (Chouin-Carneiro et. al. 2016, 
Weger-Lucarelli et. al 2016).    
 Bifenthrin is Type 1 pyrethroid that affects the central and peripheral nervous 
system of invertebrates, such as mosquitoes, by hindering the sodium channel gating, 
leading to death (Johnson et al. 2010). Insecticides can cause two different types of 
effects, direct toxic effects (causes mortality) and/or sub-lethal effects. Sub-lethal effects 
of insecticides can include behavioral (e.g., avoidance) and biological (e.g., changes in 
fecundity/fertility) changes in surviving insects after coming into contact with a non-lethal 
dose of the pesticide (Lee 2000).  
One of the most concerning consequences of the widespread use of insecticides 
is the development of insecticide resistance. Several potential pathogen vectors have 
become resistant to insecticides in some areas of the world, hence rendering chemical 
control ineffective (Feyereisen 1995). Due to the recent human epidemics related to 
ZIKV, expanding ranges of potential vectors, and increasing trends in insecticide 
resistance of mosquitoes, the need for research on ZIKV is at an all-time high (Moreno-
Madrinan et al. 2017; Richards et al. 2017a). Published information about the vector 
competence of North American Ae. albopictus mosquitoes for ZIKV is currently lacking, 
despite the ongoing epidemic (Weger-Lucarelli et al. 2016). It is widely known that not 
all mosquitoes can become infected with and transmit viruses. Biological and 
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environmental factors may impact mosquito midgut and salivary gland infection and 
escape barriers for arboviruses and the degree of these effects vary between viruses, 
mosquito populations, and mosquito species (Hardy et al. 1983). Vector competence for 
arboviruses is associated with several anatomical barriers to infection, dissemination, 
and transmission. These include a midgut infection barrier, a midgut escape barrier, a 
salivary gland infection barrier, and a salivary gland escape barrier (Bennett et al. 
2002). Vector competence is unique for each virus-vector interaction, and can be 
diverse, even in populations belonging to a single vector species (Vega-Rúa 2014). 
Therefore, it is essential to evaluate the competence of mosquitoes for virus infection 
and subsequent transmission (Chen et al. 1993).  
 Mosquito age is a biological factor that may influence vector competence. 
Viruses must undergo an extrinsic incubation period (EIP) in the potential vector before 
transmission (via saliva) to a subsequent host can occur (Cook et al. 2007). The EIP is 
impacted by biological and environmental conditions, varies between mosquito-virus 
systems, and can comprise a significant proportion of the vectors’ lifespan (Cook et al. 
2007). Another factor that can influence vector competence is the gonotrophic cycle. 
The duration of the gonotrophic cycle of a vector, and hence the frequency with which it 
feeds, can influence its vector capacity (Pant & Yasuno 1973). Furthermore, the 
immune response of mosquitoes to infection may weaken with age, hence influencing 
vector competence (Boete & Koella, 2003). 
 In the absence of a vaccine for ZIKV, the only way to prevent ZIKV infection is to 
control potential vectors. This can be accomplished by biological control measures, 
source reduction of oviposition sites, larvicides, and adulticides. Insecticides are widely 
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utilized to control many vector populations worldwide, thus reducing the risk of disease 
(Lee et al. 1997). However, mosquitoes are becoming resistant to many insecticide 
active ingredients that are currently available on the market (Rajatileka et al. 2011). 
Control programs that extensively use insecticides to suppress potential vector 
populations without using a surveillance-based targeted approach may promote 
insecticide resistance (Glunt et al. 2011). Insecticide resistance has a negative effect on 
the control of vector-borne diseases. Consequently, it would be beneficial to determine 
if exposure to sublethal doses of insecticides, such as widely used pyrethroids, impact 
the ability of mosquitoes to become infected with ZIKV (Rajatileka et al. 2011).  
 The central hypothesis is that contact with sublethal doses of insecticides will 
enhance vector competence, the ability of a mosquito to become infected with and 
subsequently transmit a pathogen, for ZIKV and that this relationship will change with 
age. Research aimed at elucidating effects of insecticide-mosquito interactions has 
largely been focused on vector control and development of resistance. Little attention 
has been given to the impacts of insecticides on vector competence. Insecticide 
pressure on mosquito populations is a continuing threat as mosquito control is the 
primary method of protecting the public from mosquito borne diseases. We investigated 
Aedes albopictus vector competence for ZIKV by the following objectives:  
1. Characterize the extent to which mosquito-bifenthrin interactions affect vector 
competence for ZIKV. 
2. Determine the extent to which mosquito age at the time of insecticide and virus 
exposure impacts vector competence for ZIKV.
 
CHAPTER II – LITERATURE REVIEW 
Zika Virus 
 Zika virus is a vector-borne flavivirus that was first identified in Uganda from a 
primate in 1947, and historically has rarely been associated with human disease 
(Lanciotti et al. 2000). In 1953, ZIKV was first identified in humans in Nigeria when the 
viral infection was confirmed in three patients (Petersen et al. 2016). Zika virus was not 
considered a public health threat by tropical medicine experts, and there were no efforts 
made to develop vaccines for infection with this virus due to the low number of human 
cases (Gatherer & Kohl 2016). Three years ago, Zika seemed too trivial for anyone to 
bother developing countermeasures (Cohen 2016). Then the ZIKV virus started 
spreading from country to country in the Southern Hemisphere in 2015, and on 
February 1, 2016, the World Health Organization (WHO) declared that Zika was a 
“public health emergency of international concern” (Cohen 2016). This declaration 
caused vaccine-makers to increase efforts in vaccine development (Cohen 2016). 
The main route of transmission for ZIKV is through bites from Aedes mosquitoes 
(i.e., Ae. aegypti), however the virus can be transmitted in humans both sexually and 
congenitally (Stettler et al. 2016). Zika virus is transmitted in both suburban and urban 
environments where vectors and humans are present (Petersen et al. 2016). Epizootics 
occur in monkeys, but it is currently unclear to what extent primates are a reservoir in 
the transmission cycle of ZIKV in humans (Gatherer & Kohl 2016). Zika virus 
transmission has been recorded in two ecologically and evolutionarily distinct 
transmission cycles, 1) an enzootic sylvan cycle, where the virus circulates between 
arboreal Aedes species (i.e., Ae. africanus Theobald) mosquitoes and non-human 
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primates and 2) a human cycle, between humans and peri-domestic or domestic Aedes 
species (i.e., Ae. aegypti) (Weaver et al. 2016).  
 Current analyses based on complete genome sequences show that ZIKV likely 
originated in Africa and diverged into two major lineages: African and Asian/American 
(Weaver et al. 2016). The African strains fall into two distinct groups: 1) Uganda cluster 
including isolates from Senegal and Central African Republic (Dick et al. 1952); 2) 
Nigeria cluster, including strains isolated in Nigeria and Senegal (Weaver et al. 2016). 
The Asian cluster includes strains isolated in Cambodia, Micronesia, and French 
Polynesia (Heang et al. 2012, Lanciotti et al. 2000, Oehler et al. 2014, Weaver et al. 
2016). Within this cluster, the American lineage emerged with the introduction of ZIKV 
into the Western Hemisphere, and now includes strains from Brazil, Puerto Rico, Haiti, 
Guatemala, and Suriname (Mlakar et al. 2016, Thomas et al. 2016, Enfissi et al. 2016, 
Weaver et al. 2016). The American ZIKV lineage is characterized by its rapid radiation, 
consistent with a pattern of major diversification, as the lineage expands into new 
territories with immunologically naïve populations (Weaver et al. 2016).  
 In 1977, ZIKV infection was confirmed in seven patients in Indonesia (Lanciotti 
et al. 2000). The symptoms exhibited by these patients included fever, headache, 
malaise, stomachache, dizziness, anorexia, and maculopapular rash. Three decades 
later in April 2007, an epidemic of rash, conjunctivitis and arthralgia was documented in 
patients by physicians in Micronesia (Lanciotti et al. 2000). In the same study, 
laboratory results identified the source of the infections as dengue virus (DENV); 
however, further analysis showed that ZIKV caused the infections. The reason for this 
misdiagnosis was because ZIKV is closely related to DENV and serologic samples may 
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cross react in some diagnostic tests for either virus (Fauci & Morens 2016). It should be 
noted that some symptoms of ZIKV infection also resemble infection with chikungunya 
virus (an alphavirus also transmitted by peridomestic Aedes spp.) (Gatherer & Kohl 
2016). The adaptation of ZIKV to an urban cycle including humans and domestic 
mosquito vectors in tropical areas where dengue is endemic suggests that the 
prevalence of ZIKV infections may be underestimated (Musso & Gublerb 2016). 
In many areas that are affected by ZIKV, seropositivity for DENV antibodies is 
high, and it may be difficult to distinguish ZIKV infections from DENV infections by 
symptoms alone (Dejnirattisai et al. 2016). Accurate diagnosis of ZIKV infection has 
been difficult given the similarities in the clinical presentation of Zika infection to other 
arboviral infections (Priyamvada et al. 2016). Although the genetics of ZIKV differs from 
DENV by approximately 41-46%, in the sequence of the envelope protein, the 
similarities are enough to allow cross-reaction of antibodies to DENV and ZIKV and to 
drive antibody dependent enhancement of infection (Dejnirattisai et al. 2016). In this 
context, ZIKV could be considered a fifth member of the dengue serocomplex 
(Dejnirattisai et al. 2016). In a contrasting study, DENV antibodies neither neutralize nor 
greatly enhance ZIKV infection in vitro (Paul et al. 2016).  
 Antibody dependent enhancement is when preexisting cross-reactive antibodies 
form virus-antibody complexes facilitate the infection of Fc gamma receptor bearing 
cells (Priyamvada et al. 2016). Fc receptors provide a link between humoral and cellular 
immune response by targeting antibody/antigen complexes to effector cells (Weinshank 
et al. 1988). Crosslinking of these receptors on macrophages results in a wide array of 
cellular responses, which include phagocytosis, secretion of reactive oxygen 
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intermediates, and lysosomal hydrolases, and ultimately mediates antibody-dependent 
cellular toxicity (Weinshank et al. 1988). This may increase the number of infected cells 
and cause higher serum viral loads, which have been shown to positively correlate with 
higher disease severity (Priyamvada et al. 2016). In contrast, other studies have 
demonstrated that monoclonal antibodies to DENV envelope proteins neutralize ZIKV in 
vitro and protect immunocompromised mice from lethal infection (Roundy et al. 2017).  
 Others suggest that previous exposure to ZIKV and DENV may pose a risk for a 
more severe disease upon exposure to heterologous virus (due to antibody dependent 
enhancement) (Stettler et al. 2016). Zika virus contains flavivirus envelope proteins that 
mediate fusion and are the main target of neutralizing antibodies, the nonstructural 
protein 1 is secreted by infected cells and is involved in immune evasion and 
pathogenesis (Muller & Young 2013). There is a high level of structural similarity 
between the flavivirus envelope proteins of ZIKV and that of other flaviviruses such as 
DENV (Sirohi et al. 2016).  
Two species of mosquitoes, Ae. aegypti and Ae. albopictus have been linked to 
nearly all known outbreaks of Zika disease; however, two other species of mosquitoes, 
Ae. hensilli (Farner) and Ae. polynesiensis (Marks) were thought to be the vectors 
responsible for the outbreaks in Yap Island and French Polynesia, respectively 
(Petersen et al. 2016). Zika virus has been infrequently identified in other species as 
well, including Ae. unilineatus (Theobald), Anopheles coustani (Laveran) and Mansonia 
uniformis (Theobald); however, vector competence studies have shown that these 
species have a low potential for transmission of ZIKV (Petersen et al. 2016). In recent 
studies, there has been evidence of vertical transmission, i.e. a virus transmitted from 
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female insects to their progeny, of ZIKV (Thangamani et al. 2016). Vertical transmission 
is one mechanism for arbovirus maintenance in nature during adverse environmental 
conditions (Thangamani et al. 2016).  
The factors that have led to the rapid spread of ZIKV are complex and poorly 
defined. Based on previous studies that worked with West Nile virus and chikungunya 
virus, it seems likely that viral factors and adaptations influencing virus transmission 
may play a role in the spread of ZIKV (Weger-Lucarelli et al. 2016). These viral factors 
and adaptations include replication rates, fitness in vitro, and the ZIKV strain being more 
efficiently transmitted by American Ae. aegypti as compared to the old-world strains of 
mosquitoes (Weger-Lucarelli et al. 2016). Weger-Lucarelli (2016) gave evidence that a 
strain of ZIKV currently circulating in the Americas does not replicate more efficiently, is 
of decreased competitive fitness, and is transmitted by American Ae. aegypti but not 
Culex species. However, more work should be carried out to evaluate the vector 
competence of different populations of mosquitoes under a variety of biological and 
environmental conditions. 
Recent outbreaks of ZIKV have occurred in the Americas and the Caribbean 
(Benelli & Mehlhorn 2016). Since data on ZIKV is limited and it is a serious public health 
concern, it is essential that researchers take a closer look at aspects of its contribution 
to birth defects (e.g., microcephaly and other developmental issues) and its relationship 
to Guillain-Barré syndrome. The World Health Organization points out the need for 
further research on this topic (WHO 2016).  
People can prevent/reduce mosquito bites by using mosquito repellants, wearing 
light colored clothing that covers as much of the body as possible, and using bed nets, 
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where needed (Benelli & Mehlhorn 2016). As ZIKV adapts to new mosquito and human 
hosts, vector-virus interactions may influence transmission potential (Weaver et al. 
2016). Recent studies indicate that ZIKV can infect several different types of cells, 
similar to other flaviviruses. Multiple cell receptors are used by ZIKV to mediate 
attachment and entry (Hamel et al. 2015, Weaver et al. 2016). Another study 
determined that ZIKV can infect human neural progenitors (cells that divide a limited 
number of times and differentiate into a restricted range of neuronal cell types) derived 
in vitro (Tang et al., 2016, Weaver et al. 2016). This occurs by inducing pluripotent stem 
cells (cells genetically modified to behave like an embryonic stem cell) (CIRM 2016), 
which suggests the virus could have the capacity to infect neuroblasts (cells that divide 
to become neurons) in vivo (Tang et al., 2016, Weaver et al. 2016). 
Mosquito Vectors 
 Aedes aegypti mosquitoes are currently implicated as the primary vector of ZIKV. 
Females of this anthroponotic mosquito species prefer to blood feed on humans, hence 
they are more likely to spread ZIKV than other types of mosquitoes, such as Ae. 
albopictus (CDC 2017). However, Ae. albopictus is also considered a ZIKV vector as it 
blood feeds on a variety of animals, including humans (Benelli & Mehlhorn 2016, Scott 
et al. 2005, Ponlawat, & Harrington 2005) and is more widely distributed in North 
America than Ae. aegypti. Aedes albopictus is found in approximately 39 states, 
whereas Ae. aegypti is found in approximately 30 states (Fauci & Morens 2016, CDC 
2017). The inadvertent transport of both Ae. aegypti and Ae. albopictus eggs occurs 
when humans transport water-holding artificial containers, such as tires and trash cans, 
from one place to another. Aedes aegypti prefers to lay eggs in artificial containers, 
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while Ae. albopictus is more opportunistic and lays its eggs in a variety of artificial and 
natural containers (i.e., leaf axils and tree holes) (O'Meara et al 1995).  
  A recent study showed that populations of Ae. aegypti and Ae. albopictus from 
the Caribbean (Martinique, Guadeloupe) and continental America (southern United 
States, French Guiana, and Brazil) were competent vectors for ZIKV strain (NC-2014-
5132); however, transmission was not observed at 4-days post infection and 7-days 
post infection for any population and transmission rates (virus detected in saliva) were 
low (Ae. albopictus 50% and Ae. aegypti 21%) and only detected at 14-days post 
infection for both species (Chouin-Carneiro et al. 2016). This study used an infectious 
blood-meal containing 1.4 mL of washed rabbit erythrocytes and 700 μL of viral 
suspension supplemented with a phagostimulant (ATP) at a final concentration of 5 mM 
(Chouin-Carneiro et al. 2016). After the infectious blood-meal, the engorged females 
were then transferred to small containers and fed with 10% sucrose solution and held in 
a chamber maintained at 28°±1°C at 80% humidity, with a 16h:8h light:dark cycle 
(Chouin-Carneiro et al. 2016). 
 There has been debate on whether or not other species of mosquitoes such as 
Culex pipiens (Linnaeus), Ae. triseriatus (Say), and Culex quinquefasciatus (Say), can 
transmit ZIKV. One study found that, after exposure to ZIKV-infected mice, Cx. pipiens 
tested negative for ZIKV after a period of 14 days (the study tested Cx. pipiens salivary 
excretions, and bodies and legs via plaque assay) (Aliota et. al. 2016a). The same 
study found that Ae. triseriatus were susceptible to ZIKV infection, but no disseminated 
infections or transmission was observed (Aliota et. al. 2016a). Aliota et al. (2016a) 
mentions that the laboratory colonies of Ae. albopictus, Ae. aegypti, Ae. triseriatus, and 
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Cx. pipiens were maintained at the University of Wisconsin-Madison but failed to 
mention the geographic origin of the colonies or the age of mosquitoes used in the 
study. In the same study, the strain of ZIKV used was PRVABC59. Aliota et al. (2016a) 
exposed mosquitoes to ZIKV-infected Ifnar  / mice. In a different study, Cx. 
quinquefasciatus became infected with ZIKV after oral exposure to an infectious blood 
meal and was able to transmit the virus to one-day-old mice (Guo et al. 2016). The Cx. 
p. quinquefasciatus used in Guo et al. (2016) were collected as larvae from Hainan 
province of southern China. Seven-day old females were exposed to ZIKV strain SZ01 
(Guo et al. 2016). Another factor that may have caused these studies to have conflicting 
results is the different methods of exposure. Guo et al. 2016 mosquito colonies were 
starved 12 hours prior to blood meal, and the blood meal was a 1:1 mouse blood:virus 
suspension that was warmed (37˚C) using a Hemotek membrane feeding system. 
Another study conversely provided evidence that neither Cx. pipiens nor Cx. 
quinquefasciatus could serve as competent vector species of transmission for ZIKV 
(Huang et al. 2016). Huang et al. (2016) also used ZIKV strain PRVABC59 to infect 
eight to 10-day old mosquitoes from colonies of Cx. pipiens from Anderson, California, 
Cx. pipiens from Ewing township, Mercer County, New Jersey, and Cx. 
quinquefasciatus from Vero Beach, Florida (Huang et al. 2016). In Huang et al. (2016), 
female mosquitoes were deprived of sugar for 48 hours, and water for 24 hours. In the 
same study, mosquitoes were blood fed using cotton pledgets that contained equal 
parts of ZIKV stock and defibrinated sheep blood, at room temperature for one hour. 
Fernandes et al. (2016) showed that neither Cx. quinquefasciatus nor any other species 
of the Culex pipiens complex has been found naturally infected with ZIKV in the 
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Americas. During the 2007 Zika outbreaks in Yap Island and in Gabon, thousands of 
Cx. quinquefasciatus were screened and none were found infected with ZIKV 
(Fernandes et al. 2016). Another supporting article’s results showed that laboratory 
colonies of Cx. quinquefasciatus and Cx. pipiens mosquitoes tested negative for ZIKV in 
their saliva, thus they were unable to transmit the Asian genotype of ZIKV (Amraoui et 
al. 2016). The conflicting findings in these studies may, in part, be the result of the 
differences in virus strain, population origin of the mosquitoes, and/or the age of the 
mosquito at time of experiment.  
 Pathogens transmitted by mosquitoes undergo an EIP in the potential vector 
before they can be transmitted to a new host. Hence, mosquito survival past the EIP is 
a critical component of a vector population’s capacity for pathogen transmission 
(McMeniman et al. 2009). Female mosquitoes that blood feed on an infectious host 
must survive the 10-14-day incubation period (differs between vector-virus systems and 
due to environmental and biological factors) of the virus before becoming infectious, and 
even after the females have become infected they may not be able to effectively 
transmit the virus (Glunt et al. 2011).  
Due to the potential for the development of insecticide resistance, alternatives to 
the use of insecticides for mosquito control should be considered (Cook et al. 2007). 
Wolbachia bacteria are currently being studied for their ability to suppress arbovirus 
transmission. This can be achieved indirectly by reducing insect lifespan or directly by 
reducing the ability of viruses and other pathogens to proliferate within the insect 
(Hoffman et al. 2011). Wolbachia pipientis is an obligate intracellular bacterium first 
observed in the reproductive tissues of Cx. pipiens (Hertig & Wolbach 1924). Wolbachia 
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bacteria are vertically inherited by transovarial transmission within invertebrate host 
populations and rarely move horizontally to infect non-target species (Cook et al. 2007). 
Wolbachia bacteria induce a number of mosquito reproductive abnormalities including 
parthenogenesis, feminization, destruction of males, and cytoplasmic incompatibility 
(the developmental arrest of insect embryos that result when females are mated to 
males that have a different Wolbachia infection status) (Cook et al. 2007). 
Wolbachia pipientis, found in the fruit fly Drosophila melanogaster, causes a 
shortened fly life span (McMeniman et al. 2009). Wolbachia pipientis can spread rapidly 
into uninfected populations of Aedes mosquitoes by inducing cytoplasmic incompatibility 
(McMeniman et al. 2009). When Wolbachia-uninfected female mosquitoes mate with 
Wolbachia-infected male mosquitoes, the resulting embryos die, whereas infected 
female mosquitoes are not affected in this way (Hoffman et al. 2011). Wolbachia is 
maternally inherited, hence providing a transmission advantage for the symbiont, 
resulting in rapid invasion of insect host populations (Hoffman et al. 2011).  
Wolbachia infection can reduce the capacity of mosquitoes to harbor and 
transmit a range of important pathogens, including DENV and (potentially) ZIKV (Dutra 
et al. 2016). A separate study found that Ae. aegypti infected with a strain of Wolbachia 
in Medellin, Colombia, displayed poor vector competence as compared to the group not 
having Wolbachia (Aliota et al. 2016b). Wolbachia can effectively invade wild mosquito 
populations as well as suppress their ability to transmit pathogens. This can be 
achieved 1) indirectly by reducing insect life span or 2) directly by reducing the ability of 
the pathogens to proliferate inside the insects (Hoffman et al. 2011).  
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 Insecticides are a common stressor for mosquitoes and may be capable of 
influencing interactions between mosquito vectors and pathogens. Insecticides can 
have lethal or sub-lethal (i.e. shortened life span) effects on potential vectors, which can 
influence the ability to transmit a pathogen (Muturi et al. 2011).  Sublethal effects 
include biological and behavioral changes of surviving insects following contact with a 
non-lethal dose of an insecticide (Lee 2000). Sublethal exposure of mosquitoes to 
neurotoxic compounds can negatively impact their sensory organs and reduce their 
ability to locate hosts (Cohnstaedt & Allan 2011). Several different studies show that the 
fecundity of Ae. aegypti was reduced when exposed to sublethal doses of different 
insecticides, including dieldrin, temephos, d-phenothrin and d-allethrin (Duncan 1963, 
Reyes-Villanueva et al 1990, Liu et al. 1986, Robert & Olsen 1989, DeCoursey and   
Webster 1953, Lee 2000). Similar findings were observed for Cx. quinquefasciatus after 
exposure to malathion (Hamdan et al. 2005). However, no studies could be found on 
the sublethal effects of Ae. albopictus exposed to an insecticide.  
Insecticide Resistance   
 The widespread usage of insecticides has resulted in the development of 
insecticide resistance in many arthropod populations. Consequently, the number of 
effective insecticides has decreased. However, the development of insecticides with 
new active ingredients is costly, especially with the expected limited long-term efficacy 
of products (Feyereisen 1995). These numerous sources of insecticides originate from 
domestic, agricultural and some veterinary products (WHO 2008). Usage of insecticides 
occurs in: agricultural use, spraying fields or seed treatment; in animal husbandry; use 
as household insecticide indoor, or in gardens; sanitary indoor use in schools, offices, 
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hospitals and other institutions; public health use in parks and urban areas and for 
vector control (e.g., malaria and dengue); medical human use to treat head lice or 
scabies; and veterinary products for pets, to treat infestations with fleas or ticks (WHO 
2008). 
 A public-private partnership called the Innovative Vector Control Consortium was 
established in 2005 to stimulate the development of new insecticides. Until new 
products are developed, careful management of resistance is needed (Hemingway 
2014). Insecticide resistance is, in part, responsible for failures in control of vectors and 
routine surveillance of the susceptibility status of the field population is vital to maintain 
effectiveness (Hasan et al. 2015). Insecticide resistance can interfere with emergency 
response usage of insecticides (Brogdon & McAllister 1998). The Entomological Society 
of America lists the recommendations from their Insecticide Resistance Management 
program including: development of insecticides with different modes of action, 
development of resistance detection tools and continuing insecticide resistance 
management education and outreach (ESA 2016).   
Insecticide resistance can be associated with mutations in the sequence of the 
target protein that induce insensitivity to the insecticide and or to the upregulation of 
detoxification enzymes (Marcombe et al. 2014). Resistance is likely pre-adaptive, in that 
before insecticide exposure, rare individuals already carry an altered genome that 
results in one or more mechanisms allowing survival from selection pressure, thus the 
development of resistance is reliant on genetic variability in a population of vectors (Li & 
Liu 2010). The ability to tolerate high doses of insecticides can occur from mutations 
that result in the overexpression of detoxification enzymes, gain-of-function mutations 
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that enable enzymes to detoxify the insecticide and decrease the sensitivity of target 
sites to the insecticide (Chan & Zairi 2013).  
 The main target site resistance mechanisms known in mosquitoes involve amino 
acid substitutions in the voltage gate sodium channel that causes a resistance 
phenotype to pyrethroids and mutations in the acetylcholine esterase sequence that 
leads to the insensitivity to organophosphates (Marcombe et al. 2014). The 
development of resistance and lack of target sites that can be exploited for mosquito 
control complicate efforts to reduce the spread of arboviruses such as ZIKV (Swale et 
al. 2016). Resistance is a genetic change in response to selection. There are two ways 
in which organisms can become resistant to insecticides, either by changing the 
effective dose available at the target site or by modifying the target site itself. Point 
mutations in the target sites are known to confer resistance (Feyereisen 1995). 
 Both dichlorodiphenyltrichloroethane and pyrethroids target the voltage gated 
sodium channels in the insects’ neurons and mutations in this target site are a common 
cause of resistance (Rajatileka et al. 2011). Although mechanisms by which insecticides 
become less effective are similar across all vector taxa, each resistance problem is 
potentially unique and may involve a complex pattern of resistance foci (Brogdon & 
McAllister 1998). Compared to other mosquito species, such as Anopheles species, 
Culex species, and Ae. aegypti, very little is known about the insecticide resistance in 
Ae. albopictus (Marcombe et al. 2014). Efforts to characterize the genetics of resistance 
is fundamental in the development of practical applications for the prevention or 
minimization of the spread and evolution of resistance development and control of 
vectors (Lu & Liu 2010).  
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 Insecticides have been in use since the 1950s, but most control programs today 
use synthetic pyrethroids. Unfortunately, pyrethroid efficacy is declining with the rise of 
resistant target populations (Nkya et al. 2012). With increasing uses of pyrethroids 
against potential vectors, it is important to monitor for pyrethroid resistance, and to 
evaluate the effect of vector age on response to pyrethroid susceptibility (Hodjati & 
Curtis 1999). One study’s results stated that, after selection for about 40 generations for 
Cx. quinquefasciatus larvae, the resistance ratio to malathion and permethrin increased 
by 52.7% and 13,130% respectively (Hamdan et al. 2005). For larval selection, the 
insecticides were diluted in ethanol prior to adding into 250ml of water in paper cups 
containing the larvae (Hamdan et al. 2005). Dosages inducing 50%-70% mortality were 
applied to larvae of each successive generation and the surviving larvae were then 
reared and bred (Hamdan et al. 2005). The same study showed that Cx. 
quinquefasciatus (F0 generation) were 0.0163 resistant to malathion and, at generation 
F40, the resistance was at 0.8598 which equals a 52.7% increase. The same population 
of Cx. quinquefasciatus was also selected for resistance to permethrin where F0 
mosquitoes started at 0.00001 resistance and changed to 0.1313 resistance by F40 
(13,130% increase) (Hamdan et al. 2005). On the other hand, after selection for 32 
generations for Ae. aegypti larvae (F32), the resistance ratio to malathion, permethrin 
and temephos was approximately 5%, 64%, and 51% different, respectively (Hamdan et 
al. 2005). Aedes albopictus larvae (F32), after 32 generations of selection pressure 
(exposure to diluted malathion and permethrin), showed a resistance ratio of 10% and 
21% to malathion and permethrin, respectively (Hamdan et al. 2005). The same 
mosquitoes showed a resistance ratio of 4% to temephos after selection for about 20 
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generations (Hamdan et al. 2005). Thus, it was determined that permethrin resistance 
developed faster compared to malathion and temephos (Hamdan et al. 2005).  
An increase in insecticide susceptibility has been shown with increasing 
mosquito age, therefore age effects should be taken into account when monitoring 
susceptibility in both lab and field studies (Rowland & Hemingway 1987, Lines & Nassor 
1991, & Hodjati & Curtis 1999). The detoxification of malathion in Anopheles stephensi 
(Liston) and An. gambiae (Giles) slows as mosquitoes age (four, eight, 12, and 16-day-
old mosquitoes tested here), and even mosquitoes that are malathion-resistant and 
permethrin-resistant at emergence become increasingly susceptible with age (Glunt et 
al. 2011). Thus, low doses of insecticides that do not significantly affect younger 
mosquitoes may remove a large number of older mosquitoes from the populations 
(Glunt et al. 2011). Another study found that a brief pre-exposure to a low dose of 
permethrin, 0.25% permethrin paper, could increase mortality resulting from a second 
exposure of the same dose 24-hours later (Hodjati & Curtis 1999). A contradicting 
study’s results for An. stephensi showed that there was no evidence that previous 
exposure to permethrin increased susceptibility to subsequent exposures, however they 
did find that older mosquitoes (12 and 16 days old) had higher susceptibility to 
permethrin (Glunt et al. 2011).  
 Insecticide resistance may impact the ability of a potential vector to transmit 
pathogens (Rivero et al. 2010). Resistance can interfere with parasite/pathogen 
development in two ways: (1) physiological modifications that accompany deployment of 
insect resistance mechanisms may hinder parasite/pathogen development in the 
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potential vector and (2) vector immune response to infection could be impacted (Rivero 
et al. 2010).  
Vector Competence 
Vector competence is the ability of a vector to become infected with and transmit 
a pathogen. Phenotypes of vector competence are controlled by genetic characteristics 
of vectors and viruses, which in turn is influenced by environmental conditions (Vega-
Rúa et al. 2014). Vector competence can depend on mosquito species and also 
pathogen strain, among other biological factors. Weger-Lucarelli et al. (2016) 
determined the vector competence of Mexican Ae. aegypti for ZIKV was highly virus 
strain specific. Infection rates were significantly higher for mosquitoes exposed to ZIKV 
strain 41525 (isolated from Aedes spp. mosquitoes collected in Senegal in 1984) as 
compared to the groups exposed to either strains MR766 (Uganda) or PRVABC59 
(Puerto Rico strain) (Weger-Lucarelli et al. 2016).  
Arboviruses have distinct infection patterns in different mosquito individuals and 
species, which may affect vector competence of populations. Vector susceptibility to 
infection varies among virus strains and mosquito species; therefore, it is important to 
continue to study vector competence (Chen et al. 1993). One study showed that Ae. 
albopictus from Singapore were highly susceptible to ZIKV (strain MR766), with 100% 
of the mosquitoes having virus found in their saliva (Wong et al. 2013). Another study 
showed data indicating less than 20% infection rates with virtually no dissemination for 
Ae. hensilli in the capital city of Yap Island, Federal States of Micronesia, using ZIKV 
(strain MR766) (Ledermann et al. 2014). In contrast, a separate study showed low 
dissemination, or transmission of several different strains of ZIKV (including MR766) in 
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Ae. aegypti from Dakar (6.3 % of the 111-specimen tested), Ae. aegypti from Kedougou 
(5.6 % of the 216-specimen tested) and Ae. unilineatus (5.3 % of the 56-specimen 
tested) (Diagne et al. 2015). However, in the same study they observed high 
dissemination rates in Ae. vittatus (27.0 % of the 37-specimen tested) and Ae. 
luteocephalus (42.2 % of the 45-specimen tested). A vector competence study with Ae. 
aegypti showed that at 14 and 21 dpi, the dissemination efficiency was equal to the 
infection rate which indicated that all infected mosquitoes had disseminated the virus 
ZIKV strain PF13/251013-18 (Richard et al. 2016).  
Vector competence varies between virus-vector interactions, hence differences in 
vector competence can be found between different populations belonging to a single 
insect species (Vega-Rúa et al. 2014). Vector competence is affected by extrinsic 
factors, such as environmental temperature (e.g., in general, increased temperature 
leads to increased virus replication) and intrinsic factors which can include heritable 
traits, host preferences, and ability of mosquitoes to become infected with a virus 
(Hardy et al. 1983). An early study suggested that genetics may be involved in 
transmission of arboviruses (Craig & Hickey 1967). Since that study, there have been 
several studies that are in support of the concept of genetic factors affecting 
transmission rates (Hardy et. al. 1983, Lu & Liu 2010).  
Richards et al. (2009, 2010) showed that the influence of mosquito age on vector 
competence of Cx. quinquefasciatus (for West Nile virus and St. Louis encephalitis 
virus) was dependent on many factors and inconsistent, showing that the vector 
competence effects of this biological factor are unpredictable under the conditions of 
their test. Depending on the conditions, young (age 3–4 days), middle-aged (age 7-8 
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days), and old mosquitoes (age 11-12 days) could show significantly higher or lower 
infection rates (Richards et al. 2010). Under some conditions (i.e., 1995 colony at low 
dose) at both extrinsic incubation temperatures, there were no effects because of 
mosquito age on either infection or dissemination rates (Richards et al. 2010). Under 
other conditions (i.e., 2007 colony at both doses and extrinsic incubation temperatures), 
there were significant effects because of age (Richards et al. 2010). In the 2007 colony, 
infection rates were sometimes higher in mosquitoes fed the low dose than those fed 
the high dose (Richards et al. 2010). These findings were unexpected, because it is 
commonly observed in many vector-pathogen systems that higher doses result in higher 
infection rates (Richards et al. 2010).  
Not all species that show vector competence in the laboratory are vectors in the 
field. Other factors, including co-occurrence with the host and the availability of 
preferred host are crucial factors that affect a mosquito’s ability to become infected with 
and transmit a virus. Vectorial capacity describes a vector's propensity to transmit a 
virus, considering human, virus, and vector interactions and is also dependent on 








CHAPTER III – MATERIALS AND METHODS  
Mosquitoes and virus. A colony of Aedes albopictus (F29) from Louisiana was 
used in this study. The mosquitoes were reared following procedures described in 
Richards et al. (2009). Mosquitoes were reared at 28C and maintained under a 14 h:10 
h light: dark cycle. These rearing conditions were standardized to generate similar sized 
individuals. One to two egg strips were placed in each of 11 plastic pans (24 cm × 36 
cm × 5 cm) containing approximately 700 mL of tap water. Larvae were fed daily with 
a2:1 mixture of liver powder and Brewer’s yeast. Pupae were transferred to 500 mL 
plastic cups containing approximately 250 mL of tap water. Male and female adults 
were allowed to emerge and mate in square metal cages (33 cm3) with mesh and 
provided 20% sucrose ad libitum (Richards et al. 2009). The same procedure was 
followed with a second set of egg strips (same mosquito colony and generation) being 
set again five days after the first set. This colony propagation procedure allowed us to 
use two different chronological ages of mosquitoes (“young” group: 6-7 days and “old” 
group: 11-12 days post-emergence when exposed to insecticide and fed infectious 
blood meal).  
 Exposure to insecticide. A standard solution of bifenthrin was prepared by 
dissolving 12.8 mg of technical-grade active ingredient (Sigma-Aldrich, St. Louis, MO, 
USA) in acetone (1000 mL) then taking 1 mL of the stock solution and dissolving it into 
100 mL of acetone to obtain the 0.128 ug/mL stock solution (Richards et al. 2017b). 
This bifenthrin dose was used because a previous study determined that this is the 
amount of bifenthrin residue detected on foliage after a barrier spray was conducted 
(VanDusen et al. 2016). Mosquitoes were exposed to the bifenthrin stock solution 
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(0.128 μg/mL) following the Guideline for Evaluating Insecticide Resistance in Vectors 
Using the CDC Bottle Bioassay (CDC 2013). Eight 250-ml Wheaton bottles were coated 
with 1 mL of bifenthrin stock. The bottles were coated the day before the bioassay and 
allowed to dry overnight, leaving bifenthrin residue on the internal surface of the bottles. 
Two groups of mosquitoes (separated by age) were exposed to the bifenthrin stock in 
bottles (100 mosquitoes/bottle), young (6-7 days old) and old (11-12 days old). The 
bottles were laid on their side and the mosquitoes remained in the bottle for a 30-minute 
exposure period. After bifenthrin exposure, mosquitoes were chilled and transferred to 1 
L cardboard cages (returned to incubators at 28°C) with mesh and provided water.  
 For the control group, eight 250-ml Wheaton bottles were coated with 1 mL of 
acetone stock. The bottles were coated the day before the bioassay and allowed to dry 
overnight, leaving a sterilized interior surface. Two groups of mosquitoes (separated by 
age) were exposed to the acetone stock in bottles (100 mosquitoes/bottle), young (6-7 
days old) and old (11-12 days old). The bottles were laid on their side and the 
mosquitoes remained in the bottle for a 30-minute exposure period. After the acetone 
exposure, mosquitoes were chilled and transferred to 1 L cardboard cages with mesh 
and provided water. Treatment and control groups were fed an infectious blood meal 24 
h post-exposure to the bifenthrin.  
 Mosquito infection. Adult female mosquitoes at 7-8 (young) and 12-13 (old) 
days post-emergence were allowed to feed on cotton pledgets containing a 1:1 mixture 
of defibrinated bovine blood (Hemostat, Dixon, CA) and Zika virus (Puerto Rican isolate: 
PRVABC59) supernatant (freshly harvested from Vero cell culture) warmed at 35 C for 
10 minutes (Richards et al. 2009; 2017b). Two aliquots of 0.1 mL of infected blood were 
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each added to 0.5 mL RNA Later and held at -80C until processing to determine blood 
meal titer (Richards et al. 2010). We observed a blood feeding rate of approximately 10-
20% (data not shown). Mosquitoes were chilled and fully engorged mosquitoes from 
each treatment group were transferred to separate 1 L cardboard cages with mesh 
screening and maintained in incubators for 7 days at 28C and provided 20% sucrose 
ad libitum (Richards et al. 2009).   
  Blood meal and mosquito processing. Mosquitoes surviving the 7-day 
incubation period were removed from their cages and killed with cold. Their legs and 
wings were removed with forceps. To prevent contamination of our samples, forceps 
were soaked in 70% ethanol and flamed between processing of each mosquito 
(Richards et al. 2010). Each mosquito body and set of legs was placed in a separate 
tube containing 0.5 mL RNA Later with two 4.5 mm glass beads and stored at -80C 
until processing for ZIKV. The mosquito bodies and legs were titrated separately in 0.5 
mL RNA Later and stored at -80C until processing. Samples were homogenized at 25 
Hz for 3 min (TissueLyser; Qiagen, Valencia, CA) and centrifuged at 4C and 3,148 × g 
for 4 minutes (Richards et al. 2009) prior to RNA extraction.  
 Virus assays. Nucleic acids were extracted from each sample using QIAmp viral 
RNA kit (Qiagen, Valencia, CA, USA) following the manufacturer’s protocol (Richards et 
al. 2017a). The amount of viral RNA in each sample was determined using a 
LightCycler® 480 system (Roche) and Superscript III One-Step Quantitative reverse 
transcript-polymerase chain reaction (qRT-PCR) kit (Invitrogen, Carlsbad, CA) for 
quantitative real-time Taq-Man RT-PCR (Richards et al. 2017a). Standard curves used 
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in qRT-PCR were based on 10-fold dilutions of known ZIKV titers determined by plaque 
assay (Richards et al. 2017a). 
 Virus found in the body but not the legs represented a non-disseminated infection 
limited to the midgut (Richards et al. 2010). Virus found in both the body and legs was 
considered a disseminated infection (Richards et al. 2010). The infection rate was the 
percentage of mosquitoes with ZIKV-infected bodies. The dissemination rate was the 
percentage of mosquitoes with ZIKV-infected bodies that also had infected legs.    
Statistical analysis. Viral titers in freshly blood fed mosquitoes as well as body, leg, 
and saliva titers at the end of the extrinsic incubation period were log transformed [log(x 
+ 1)] to improve normality prior to analysis of variance (ANOVA) with the generalized 
linear model (GLM) procedure in SAS (SAS Institute, Cary, NC). An ANOVA was 
carried out to examine any differences in virus titers between mosquito ages in the 
insecticide exposure and control groups. Separate ANOVA tests were conducted to 
determine differences, if any, between treatment groups (bifenthrin or control) and 
mosquito ages (young or old) for body and leg titers of virus positive mosquitoes at the 
end of the 7-day extrinsic incubation period. Individual mosquitoes were treated as 
experimental units in these analyses. If significance (P < 0.05) was observed in an 
ANOVA, then a Duncan multiple comparison procedure was performed to determine 
which means were significantly different.  
 We conducted two separate analyses of the probability of different body parts 
(bodies or legs) becoming infected with ZIKV. We analyzed the infection and 
dissemination rates with respect to mosquito age (young or old) or treatment (bifenthrin 
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or control) using Pearson chi-square tests to evaluate independence in contingency 




















CHAPTER IV – RESULTS 
Virus titer of blood meals, feeding rate, sample size and mortality rates 
 The titer of the ZIKV blood meal delivered to all groups was 6.3 ± 0.0 (mean ± 
SE) logs pfu/mL (n = 1). The observed blood meal feeding rate ranged between 10-20% 
among the four groups and initial sample sizes (blood fed mosquitoes) were: old control 
(𝑛 = 29), young control (𝑛 = 63), old bifenthrin (𝑛 = 63), young bifenthrin (𝑛 = 50). The 
mortality rates among the four groups are shown in Table 1. The group experiencing the 
highest mortality at the end of the incubation period were old mosquitoes exposed to 
bifenthrin (78%, P=0.0017) and the lowest mortality rate was seen in young mosquitoes 
in the control group (33%).  
ANOVA and Duncan multiple comparison procedure for mosquito age on infection and 
dissemination rates and virus titers. 
 No significant differences were observed in infection rates by treatment group 
(bifenthrin compared to control) in either young (P=0.357) or old (P=0.500) mosquitoes 
(Tables 2 and 3). Dissemination rates were not significantly different between young 
(P=0.115) control and bifenthrin-exposed mosquitoes; however, old bifenthrin-exposed 
mosquitoes showed significantly (P=0.0002) higher dissemination rates than old control 
mosquitoes (Tables 2 and 3). 
 Within the control group, there were no significant differences in infection rate 
(P=0.390) or dissemination rate (P=0.125) observed between ages (Table 4). For 
mosquitoes exposed to bifenthrin, no significant age differences were observed in 
infection rate (P=0.652); however, old mosquitoes exposed to bifenthrin exhibited  
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significantly (P< 0.0001) higher dissemination rates than young mosquitoes exposed to 
bifenthrin (Tables 2 and 4). 
 Young mosquitoes showed no significant differences (P=0.071, F=3.39, DF= 
1,53) in body titers for those exposed to either control or bifenthrin. However, body titers 
of old mosquitoes exposed to bifenthrin were significantly (P=0.013, F=7.01, DF=1,30) 
higher than those of old mosquitoes in the control group (Tables 2 and 5). Leg titers 
were significantly higher in bifenthrin-exposed mosquitoes and this was exhibited in 
both young (P< 0.0001, F=23.76, DF= 1,53) and old mosquitoes (P=0.003, F= 10.37, 
DF=1,30) (Tables 2 and 5). No significant differences were found in the body titers 
between the young and old bifenthrin groups, however significantly higher body titers 
were observed in old mosquitoes compared to young mosquitoes within the control 
group (P=0.003, F (F-statistic)=9.84, DF (degrees of freedom)= 1,39)(Table 6). Leg 
titers were significantly higher in old mosquitoes and this was observed in both control 
(P=0.001, F=12.04, DF=1,39) and bifenthrin-exposed (P=0.018, F=6.02, DF=1,44) 











CHAPTER V – DISCUSSION 
We investigated the impact of mosquito age and insecticide exposure on ZIKV 
infection and dissemination in Aedes albopictus. We show that, for this population of 
mosquitoes, age at the time of insecticide exposure significantly increases the mortality 
rate of the mosquito. This could be due to the older mosquitoes having a more 
weakened immune system and are unable to fight of the insecticide exposure. This 
finding is consistent with reported rates of mortality in Ae. aegypti where the mortality 
differed significantly between sugar fed 3 d and 14 d old mosquitoes with the older 
group having the highest mortality (Rajatileka et al. 2011). The same study showed that 
providing a blood meal did not significantly impact mortality in the 3 d and 14 d old 
mosquitoes with mortality increasing with increasing age, suggesting that age, rather 
than diet, was the most important factor (Rajatileka et al. 2011). Hodjati & Curtis (1999) 
showed similar findings in Anopheles stephensi where older (10 d old) mosquitoes 
exposed to 0.25% permethrin-impregnated paper (WHO test kits) showed significantly 
higher mortality compared to younger (newly emerged) mosquitoes, regardless of 
resistance or blood fed status.  
We show that, in old mosquitoes tested here, sublethal bifenthrin exposure 
significantly impacts the ability of ZIKV to disseminate out of the midgut. However, no 
significant differences were observed between body infection rates and all groups 
experienced a high degree of infection (≥ 94%). The high infection rate for all groups is 
due to infection was determine by looking at the bodies and all the mosquitoes took an 
infectious blood meal so the chance for infection in the body is high whereas in 
dissemination (infection in the legs) the virus must be able to escape the midgut barrier. 
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It is possible in older mosquitoes, due to age and compounded by the body trying to 
fight off the effects of the insecticide, there is a weakness in the ability of the midgut 
barrier to contain the virus. While the mosquito may be up-regulating detoxifying 
enzymes, which may inhibit the ability of the midgut barrier, thus allowing the virus to 
disseminate to the legs. Old mosquitoes exposed to bifenthrin exhibited the highest 
rates of infection and dissemination, as well as the highest body and leg titers. This 
could be the result of a lower immune response in older mosquitoes, as suggested by 
Boete & Koella’s (2003). Here, we used body and leg infection as a proxy for salivary 
gland infection and transmission. However, not all mosquitoes experiencing a 
disseminated infection will be capable of transmitting the virus in saliva. Future studies 
should focus on how sublethal insecticide exposure may impact the midgut and salivary 
gland infection and escape barriers in mosquitoes under a variety of biological and 
environmental conditions.  
We also show that, among bifenthrin-exposed mosquitoes, age significantly 
impacts the ability of ZIKV to disseminate out of the midgut, such that old mosquitoes 
have significantly higher dissemination rate that younger mosquitoes. Richards et al. 
(2009) concluded that mosquito age is an important factor that can affect vector 
competence for West Nile virus, but the degree of variation may change in different 
mosquito populations and/or environmental conditions. The same study also noted that 
mosquito age has dynamic properties in the field, which indicates that vector 
competence of field populations will likely change as well (Richards et al. 2009). This 




We expect the relationships observed here to change under different biological 
and environmental conditions, and with different mosquito populations and virus strains. 
Future studies should explore these factors. We show that age and insecticide exposure 
affects dissemination rates, and this should be considered when developing strategies 
to reduce vector populations and pathogen transmission. Impacts of insecticides should 
be considered in risk assessments of potential vector populations. These findings 
illustrate the importance of evaluating if the insecticides we use in our vector control 
programs are effective. By determining the best product and concentration that works 
best for your area the number of mosquitoes surviving the exposure can be reduced. 
Also, vector control programs should focus on younger mosquitoes because younger 
mosquitoes have a lower likelihood of coming in to contact with an infected host and 
then spreading a virus like ZIKV. Whereas if a program focused on older mosquitoes 
there is more time for that population of mosquitoes to spread pathogens. Younger 
mosquitoes have a stronger immune response to insecticide exposure which is why 
testing is so important. 
Strengths and Limitations of the Study 
 Literature examining the relationship between vector competence is limited. This 
study adds to the growing understanding of how sublethal exposure impacts vector 
competence. This study used a lab generated, nonresistant, colony of Ae. albopictus 
mosquitoes, future studies need to examine field populations to determine how resistant 
colonies are impacted by sublethal exposures. There are multiple strains of ZIKV, this 
study only looked at the ZIKV strain PF13/251013-18, future studies need to look at the 
other known strains of ZIKV. This study only had a 7-day incubation period future 
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CHAPTER VI – CONCLUSION 
Insecticides are common stressors for mosquitoes and they are capable of 
influencing interactions between mosquito vectors and pathogens. Vector competence 
was significantly impacted by age and insecticide exposure in this study. There are 
several factors that could impact these findings including, but not limited to: mosquito 
species, mosquito population, mosquito age, virus strain, method of exposure of 
mosquitoes to insecticide, type of insecticide used, and insecticide dose. Consequently, 
further studies should be conducted to evaluate a variety of factors that may interact to 
influence measures of vector competence, including transmission. The implications of 
this type of study could influence how we look at vector control methods and their role in 
disease prevention. Therefore, it is vital for us to investigate these types of interactions, 
so we can better understand the interplay between insecticide exposure and potential 












TABLE 1. Mortality Rate of Aedes albopictus  





TABLE 2. Percentages of Infection and Dissemination and Mean Titers ± SE of Aedes 

















Old Control 16 15(94)a 3.8±0.3b 3(19)b 0.9±0.3a 
Young Control 25 25(100)a 4.7±0.1a 1(4)b 0.1±0.1b 
Old Bifenthrin 16 16(100)a 4.9±0.3a 14(88)a 2.6±0.4a 
Young Bifenthrin 30 29(97)a 4.3±0.2a 5(1)b 1.6±0.3b 
The mean titers (log10 plaque forming units (pfu) ZIKV/ mL) ± standard error(SE) and 
rates of infection (% with ZIKV positive bodies) for Aedes albopictus fed ZIKV-infected 
blood meals (6.3 log10 pfu blood meal titer) and held at 28°C for 7d. 1Same letter in the 
same column not significantly different between control and bifenthrin groups by Fisher’s 
Exact test. 2Same letter in the same group not significantly different between ages within 









(Day 7) Mortality (%)1 
Old Control 29 16 45b 
Old Bifenthrin 63 14 78a 
Young Control 36 24 33b 
Young Bifenthrin 50 28 44b 
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TABLE 3. Infection and Dissemination Rate Differences for Age between Treatment 
Groups of Aedes albopictus Exposed to Zika Virus and Maintained at 28C for 7 Days. 




Young Control 0.357 0.115 
 
Bifenthrin   
Old Control 0.500 0.0002 
 
Bifenthrin   





TABLE 4. Infection and Dissemination Rate Differences for Groups Between Ages of 
Aedes Albopictus Exposed to Zika Virus and Maintained at 28C for 7 Days. 




Control Old 0.390 0.125 
 
Young   
Bifenthrin Old 0.652 <0.0001 
 
Young   







TABLE 5. ANOVA Results of Body and Leg Titer (logs pfu ZIKV/mL) Differences for Age 
Between Groups of Aedes albopictus Exposed to Zika Virus and Maintained At 28C for 
7 Days.      











Young Control 1, 53 3.39 23.76 0.071 <0.0001 
 
Bifenthrin    
 
 
Old Control 1, 30 7.01 10.37 0.013 0.003 
 
Bifenthrin    
 
 




TABLE 6. ANOVA Results of Body and Leg Titer (logs pfu ZIKV/mL) Differences for 
Groups Between Ages of Aedes albopictus Exposed to Zika Virus and Maintained at 
28C for 7 Days. 
Significant values are presented in bold type. 
 
 













Control Old 1, 39 9.84 12.04 0.003 0.001 
 
Young      
Bifenthrin Old 1, 44 3.35 6.02 0.074 0.018 
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